Breast cancer, a disease in which malignant cells form in the tissues of the breast, is the most common type of cancer (other than skin cancer) among women. Less than 1 percent of breast cancers occur in men. The risk of getting breast cancer increases with age, and inherited gene mutations or a family history of breast cancer may increase the risk.
At Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, our breast cancer experts deliver excellent patient care in a research context. Our Comprehensive Breast Health Services (CBHS) facility in Dublin, Ohio, about 20 minutes from The James and the main Ohio State campus, evaluates and treats more than 500 breast cancer patients annually.
CBHS medical, surgical, and radiation oncologists are specialists in breast cancer. CBHS Co-Directors Charles Shapiro, MD, and William Farrar, MD, are nationally recognized by their peers as being among the “Best Doctors in America,” “Top Doctors in America,” and the “Best Cancer Doctors in America.”
Physicians and researchers at the OSUCCC – James work together to make important discoveries that establish new approaches to breast cancer. Examples include:
• William Carson, MD: Making standard therapies work better by enhancing the immune system IL-12, herceptin, paclitaxel
• Pravin Kaumaya, PhD: HER2 peptide vaccine
• Barbara Andersen, PhD: Stress and immunity project that evaluates the effect of stress on immune function in breast cancer survivors
• Electra Paskett, PhD, MsPH: Lymphedema and other survivorship issues in breast cancer survivors
• Charles Shapiro, MD: Osteoporosis in young women with breast cancer; incorporating biologic agents in combination with known breast cancer chemotherapy drugs (paclitaxel and bortezumab, paclitaxel and suramin, docetaxel and bevacizumab)
• Richard Love, MD: Effects of ovarian ablation in breast cancer
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন